UCLA 17th Annual UCLA Liver Diseases Symposium 2024
UCLA 17th Annual UCLA Liver Diseases Symposium 2024
Regular price
$10.00 USD
Regular price
$10.00 USD
Sale price
Unit price
per
Couldn't load pickup availability
UCLA 17th Annual UCLA Liver Diseases Symposium 2024
Regular price
$10.00
Regular price
$10.00
Sale price
Unit price
per
UCLA 17th Annual UCLA Liver Diseases Symposium 2024
Include: 8 videos + 9 pdfs, size: 2.69 GBTarget Audience: physicians, hepatologists, radiologists, and surgeons
Information:
Date & Location: Saturday, October 26, 2024, 7:15 AM – 2:00 PM, Hyatt Regency Westlake, Westlake, CA
Overview
The 17th Annual UCLA Liver Diseases Symposium will provide a state-of-the-art update and scientific exchange on prevalent liver diseases and their complications using a multi-disciplinary approach with hepatologists, radiologists and surgeons.
Target Audience
Specialties – Family Medicine, Internal Medicine, Radiology, Surgery
Professions – Advanced Practice Nurse, Fellow/Resident, Nurse, Other, Physician, Physician Assistant
Objectives
At the conclusion of this activity, learners will be able to:
- Diagnose and manage patients with advanced liver disease and be better able to prognosticate and risk stratify those patients for medical procedures.
- Understand the current process of evaluation, listing and organ allocation in liver transplantation.
- Identify the risks and benefits of interventional radiology (IR) procedures for the management and treatment of clinically significant portal hypertension in patients with advanced liver disease.
- Use evidence-based recommendations in the evaluation and management of hepatocellular carcinoma (HCC).
- Discuss the role of current and recently approved second line therapies in the treatment of primary biliary cholangitis (PBC).
- Evaluate and properly stratify patients with metabolic dysfunctionassociated steatotic liver disease (ie, fatty liver), and develop tailored therapies to prevent disease progression.
- Review treatment options for patients with alcohol hepatitis and optimal long-term care.
- Identify the most common causes of drug induced liver injury (DILI) and learn to assess which cases are likely to resolve or progress.
- Diagnose acute liver failure, risk stratify patients, and identify those likely to recover and those likely to require a liver transplant.
Topics:
- 230443_BROCHURE.pdf
- Changes in Evaluation, Listing, and Organ Allocation in Liver Transplantation.mp4
- Current Evaluation and Treatment of Metabolic Dysfunction Associated Liver Disease.pdf
- Evaluating-Induced Liver Injury – When to be Concerned.mp4
- Evaluating-Induced Liver Injury – When to be Concerned.pdf
- Multidisciplinary Approach for Patients with Alcohol Liver Disease Including Those with Alcohol Hepatitis – Perspectives from Hepatology and Addiction Medicine.mp4
- Multidisciplinary Approach for Patients with Alcohol Liver Disease Including Those with Alcohol Hepatitis – Perspectives from Hepatology and Addiction Medicine.pdf
- New Concepts in Portal Hypertension and Risk Stratification of Patients with Liver Cirrhosis.mp4
- New Concepts in Portal Hypertension and Risk Stratification of Patients with Liver Cirrhosis.pdf
- New Therapies in Primary Biliary Cholangitis and Approaches in Autoimmune Hepatitis.mp4
- New Therapies in Primary Biliary Cholangitis and Approaches in Autoimmune Hepatitis.pdf
- Panel Case Discussion Multi-Disciplinary Approach to Liver Cancer.mp4
- Panel Case Discussion Multi-Disciplinary Approach to Liver Cancer.pdf
- Panel Discussion- Acute on Chronic and Fulminant Liver Failure.mp4
- Panel Discussion- Acute on Chronic and Fulminant Liver Failure.pdf
- Radiologic Treatment of Refractory Hepatic Encephalopathy, Ascites, and Variceal Bleeding.mp4
- Radiologic Treatment of Refractory Hepatic Encephalopathy, Ascites, and Variceal Bleeding.pdf
